Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting

Background: Most hospitals still use unfractionated heparin (UFH) as the primary agent for venous thromboembolism (VTE) prophylaxis in the hospital setting due to ease of use and insignificant cost. However, the risk of heparin-induced thrombocytopenia (HIT) has led some groups to favor other option...

Повний опис

Бібліографічні деталі

Автори:	Harry Menon, Adip Pillai, Jeanine Aussenberg-Rodriguez, John Ambrose, Irini Youssef, Elizabeth G Griffiths, Omar Al Ustwani
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-10-01
Серія:	Avicenna Journal of Medicine
Предмети:	anticoagulation heparin-induced thrombocytopenia low molecular weight heparin
Онлайн доступ:	http://www.thieme-connect.de/DOI/DOI?10.4103/ajm.AJM_78_18
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!